SCHEMBL5859620

SCHEMBL5859620

FC(OC1CCCC[N]1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.36
CHRM2 P08172 2/20 0.33
ADRA2A P08913 2/20 0.33
CHRM1 P11229 2/20 0.33
DRD1 P21728 2/20 0.33
SLC6A2 P23975 2/20 0.33
ADRA1A P35348 2/20 0.33
OPRM1 P35372 2/20 0.33
DRD3 P35462 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KCNH2 Q12809 2/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
CHRM3 P20309 1/20 0.33
HRH2 P25021 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003228 0.83 DRD3 (0.42) IDO1CHRM2ADRA2ACHRM1DRD1
SCHEMBL9021303 0.74 IDO1 (0.36) IDO1GAAL3MBTL1HRH1SIGMAR1
SCHEMBL1828238 0.70 HRH1 (0.40) SLC6A2SLC6A3SLC6A4HRH1LMNA
SCHEMBL11070013 0.69 HRH1 (0.39) IDO1SLC6A2SLC6A3GAASLC6A4
SCHEMBL447548 0.67 PSEN1 (0.39) OPRM1SIGMAR1LMNAHRH3MAPK1
SCHEMBL2254431 0.66 L3MBTL1 (0.33) IDO1CHRM2ADRA2ACHRM1DRD1
SCHEMBL2202292 0.66 GAA (0.37) IDO1GAAL3MBTL1SIGMAR1CYP2D6
SCHEMBL2092663 0.66 SLC6A2 (0.39) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL8702225 0.65
SCHEMBL1830085 0.65 HRH1 (0.41) SLC6A2SLC6A3GAASLC6A4HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160075680-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES FUNDACION IMDEA NANOCIENCIA (ES) 2016-03-17 US claimed
EP-2992002-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES Fundación Imdea Nanociencia (ES) 2016-03-09 EP claimed
WO-2014177533-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES FUNDACIÓN IMDEA NANOCIENCIA (ES) 2014-11-06 WO claimed
EP-2799443-A1 Modified solid support for the synthesis of oligonucleotides Fundación Imdea Nanociencia (ES) 2014-11-05 EP claimed
US-7135564-B1 Reusable solid support for oligonucleotide synthesis UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2006-11-14 US claimed
EP-1091972-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2001-04-18 EP claimed
WO-2000001711-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-13 WO claimed
US-20160075680-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES FUNDACION IMDEA NANOCIENCIA (ES) 2016-03-17 US disclosed
EP-2992002-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES Fundación Imdea Nanociencia (ES) 2016-03-09 EP disclosed
WO-2014177533-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES FUNDACIÓN IMDEA NANOCIENCIA (ES) 2014-11-06 WO disclosed
EP-2799443-A1 Modified solid support for the synthesis of oligonucleotides Fundación Imdea Nanociencia (ES) 2014-11-05 EP disclosed
US-7135564-B1 Reusable solid support for oligonucleotide synthesis UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2006-11-14 US disclosed
EP-0877751-B1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIV TECHNOLOGIES INT (CA) 2003-10-15 EP disclosed
US-6043353-A FOR SOLID PHASE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC. (CA) 2000-03-28 US disclosed
US-6015895-A REACTING A LINKER COMPOUND WITH A HYDROXY GROUP OF A NUCLEOSIDE AND A SOLID SUPPORT CAPABLE OF ESTERIFICATION; LINKER IS STABILE AGAINST SPONTANEOUS HYDROLYSIS AND EASILY CLEAVED WHEN NECESSARY UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-18 US disclosed
WO-2000001711-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-13 WO disclosed
EP-0877751-A1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1998-11-18 EP disclosed
EP-0876390-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS, PROCESS FOR PRODUCTION THEREOF AND PROCESS FOR USE THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1998-11-11 EP disclosed
WO-1997023497-A1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1997-07-03 WO disclosed
WO-1997023496-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS, PROCESS FOR PRODUCTION THEREOF AND PROCESS FOR USE THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1997-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160075680-A1 MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES POLR2H, POLRMT, POLR2E IDO1 4835/4885CHRM2 4529/4885ADRA2A 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.